|Last Price$9.70||Day Change (%)-0.31%|
|Open Price$9.70||Day Change ($)-0.03|
|Day Range9.70–9.70||52-Week Range9.49–10.98|
As of Tue 03/28/2017 | USD
Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...
Inside Clipper Fund's makeover.
Recent deals have been driven more by tax strategies than therapeutic synergies.
Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.
Inspired by a vessel that brought Swedes to the New World, Draper has built a firm that emphasizes results over renown.
We believe breakups could unlock value for big pharma shareholders.
ETFs provide a great means to gain exposure to this battered health-care giant.
Things look grim, but investors who can bear it could benefit.